Clinical Trials Logo

Chronic Non-malignant Pain clinical trials

View clinical trials related to Chronic Non-malignant Pain.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03761277 Completed - Chronic Pain Clinical Trials

Embrace TDD: Post-Market Study to Evaluate Intrathecal Morphine as an Alternative to Systemic Opioids for Chronic Pain

Start date: January 16, 2019
Phase: Phase 4
Study type: Interventional

This is a prospective, multi-center, post market study to evaluate Intrathecal (IT) preservative-free morphine sulfate (PFMS) using the SynchroMed™ II infusion system as an alternative to systemic opioids for the treatment of chronic, intractable, non-malignant primary back pain with or without leg pain.

NCT ID: NCT02113592 Completed - Clinical trials for Chronic Non-malignant Pain

Pain Program for Active Coping & Training

PPACT
Start date: April 10, 2014
Phase: N/A
Study type: Interventional

The overall aim of this study is to adopt an integrative rehabilitation approach for helping patients adopt self-management skills for managing chronic pain, limiting use of opioid medications, and identifying exacerbating factors amenable to treatment (e.g., depression, sleep problems) that is feasible and sustainable within the primary care setting.

NCT ID: NCT01888146 Completed - Clinical trials for Chronic Non-malignant Pain

Pain Program for Active Coping & Training

PPACT-UH2
Start date: May 2013
Phase: N/A
Study type: Interventional

The overall aim of this study is to adopt an integrative rehabilitation approach for helping patients adopt self-management skills for managing chronic pain, limiting use of opioid medications, and identifying exacerbating factors amenable to treatment (e.g., depression, sleep problems) that is feasible and sustainable within the primary care setting.

NCT ID: NCT00485225 Completed - Clinical trials for Chronic, Non Malignant Pain

Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain

Start date: June 2007
Phase: Phase 2
Study type: Interventional

Two stage study looking at different titration schedules in patients with moderate to severe non-malignant chronic pain. Up to 80 patients at approximately 15 centers in the US to be enrolled. Study participation is approximately 3 months.

NCT ID: NCT00312195 Completed - Clinical trials for Chronic Non-malignant Pain

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain

Start date: March 2001
Phase: Phase 3
Study type: Interventional

The objective of this study is to demonstrate the effectiveness and tolerability of the buprenorphine transdermal system (5, 10 and 20) in comparison to matching placebo transdermal system in subjects with chronic nonmalignant pain syndromes currently controlled by oral opioids. The double-blind treatment intervention duration is 2 weeks during which time supplemental analgesic medication (acetaminophen) will be provided to all subjects in addition to study drug.